INDISCRIMINATE USE OF ERECTILE DYSFUNCTION MEDICATIONS AMONG YOUNG PEOPLE

Abstract

 Introduction: Introduction: The indiscriminate use of phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction among young individuals has increased significantly, driven by a performance-oriented culture and misinformation. Drugs such as sildenafil and tadalafil are frequently used recreationally without medical supervision, posing physical health risks and psychosocial concerns. Objective: To analyze the literature regarding the indiscriminate use of erectile dysfunction medications among youth, identifying associated factors, clinical risks, and biopsychosocial impacts. Method: An integrative literature review conducted in MEDLINE/PubMed and the Virtual Health Library (VHL/BVS) databases, considering articles published between 2016 and 2026 in English and Portuguese. Search descriptors were combined using the Boolean operator AND. Three studies met all inclusion criteria. Results: The reviewed literature indicates that young men consume sildenafil and tadalafil without a clinical diagnosis, driven by curiosity, performance anxiety, peer influence, and the desire to enhance sexual stamina. Concomitant intake with alcohol and illicit substances is common, resulting in adverse effects such as headaches, hypotension, tachycardia, facial flushing, and psychological dependency. Conclusion: Unprescribed PDE5 inhibitor use among young adults represents a multifaceted public health challenge fueled by societal expectations of masculinity. Multidisciplinary educational initiatives and regulatory vigilance are essential to foster sexual health literacy and prevent self-medication.